The medical device contract manufacturing market is on a robust growth trajectory, projected to reach USD 268.6 billion by 2035, expanding at a compound annual growth rate (CAGR) of 11.89% from 2026 to 2035. This rapid expansion is attributed to the increasing outsourcing of production from Original Equipment Manufacturers (OEMs) to specialized Contract Manufacturing Organizations (CMOs).
What Happened
The market was valued at USD 87.32 billion in 2025, with the U.S. market expected to surpass USD 93.2 billion by 2035. The European market is also on a significant growth path, projected to reach USD 71.26 billion within the same period. The rise in OEM outsourcing is largely driven by the need to manage stringent regulatory requirements, escalating product complexity, and manufacturing costs. CMOs are increasingly investing in advanced manufacturing technologies, such as robotics, AI-assisted quality checks, and precision engineering, to enhance production efficiency and speed up the commercialization of medical devices.
Leading players in the market include Jabil Inc., Flex Ltd., and Plexus Corp., among others. The market is segmented by service type, with device development and manufacturing services dominating, capturing around 54.3% of the revenue share in 2025. The quality management and testing segment is the fastest-growing area, partly due to the tightening of medical device regulatory requirements under the EU MDR and the FDA’s enhanced inspection programs.
What This Means for Your Business
For U.S. operators in the AECM industry, the booming medical device contract manufacturing market presents numerous opportunities. Companies that can offer advanced manufacturing capabilities and regulatory compliance expertise will be well-positioned to capture market share. The demand for connective health devices, minimally invasive surgical tools, and combined drugs-device products is expected to drive substantial business opportunities for contract manufacturers. Investments in automation, digital manufacturing processes, and AI-driven process monitoring will be crucial for maintaining competitive positioning.
Compliance with stringent regulations, such as the EU MDR and FDA standards, will be pivotal. Companies must ensure robust quality management systems to meet these requirements. As the market grows, there's a potential for increased federal funding opportunities for technological advancements and manufacturing innovations.
What US Operators Should Watch
Decision-makers should closely monitor federal deadlines and procurement windows related to medical device manufacturing. Staying ahead of regulatory changes and ensuring timely compliance with CMMC and NIST standards will be essential. Companies should also track bid opportunities for government contracts as the industry landscape evolves.
Is your firm ready for what’s next?
VisioneerIT helps AECM and government contractors modernize operations, achieve compliance, and implement AI.
Explore VisioneerIT Solutions →
